What they do
DeepEcho develops artificial intelligence software to support fetal ultrasound examinations. Its technology recognises standard ultrasound views and helps professionals work with fetal measurements. The company brings together medical and AI expertise, with tools intended to assist prenatal imaging workflows.
The FDA record lists clearance of the DEEPECHO device on 23 May 2025 under K242594. Its indications cover reading and measurement assistance for trained healthcare professionals, for patients aged 18 or older during weeks 14–41 of pregnancy.
DeepEcho also works on access to prenatal imaging in underserved settings. Its December 2025 GSMA grant supports scaling a pilot, including planned mobile and training activities.
Products and applications
- Ultrasound view recognitionIdentification of standard fetal ultrasound views to assist examination workflows.
- Fetal measurement assistanceTools that help professionals compute biometric measurements from suitable ultrasound images.
- Examination managementImage uploads, patient examination records and reporting workflows.
- Remote ultrasound toolsCompany-described remote review and guidance capabilities for prenatal imaging.